Adiponectin has been recently described to be an anti-inflammatory and cardioprotective cytokine as low levels of adiponectin have been revealed in patients with severe coronary artery disease (CAD) and left ventricular hypertrophy with diastolic dysfunction [15,16,17]. This evidence concerns the gene ADIPOQ and coronary artery disorder.